Should Affirm’s Profitability Gains and Bed Bath & Beyond Partnership Require Action From Affirm Holdings (AFRM) Investors?

• In recent days, Affirm Holdings reported quarterly revenue of US$1.04 billion and net profit of US$102.9 million, while Bed Bath & Beyond enabled Affirm installments across its brands.
• This combination of improving profitability, fresh merchant adoption and ongoing debate over leverage and capital efficiency has sharpened focus on Affirm’s business quality.
• We’ll now examine how Affirm’s move into Bed Bath & Beyond’s checkout, alongside profitability gains, influences its existing investment narrative.

Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Affirm Holdings Investment Narrative Recap

To own Affirm, you need to believe its installment network can keep adding merchants and users while turning that scale into sustainably profitable lending. The latest Bed Bath & Beyond rollout and improving net income support that story, but the key near term catalyst remains broader merchant adoption across categories, while the biggest risk still sits on the balance sheet: high leverage and questions about how efficiently Affirm can fund growth. This news does not materially change that risk.

The Bed Bath & Beyond partnership is especially relevant, because it shows Affirm still winning branded checkouts even as debate intensifies over its negative return on equity and elevated net debt to EBITDA. That combination of new volume potential with capital structure concerns is exactly what drives the disagreement in analyst ratings, where some see compounding value in each new merchant win and others focus squarely on funding costs and dilution risk.

Yet behind the improving profitability story, investors also need to be aware of the ongoing concerns about potential equity dilution and...

Read the full narrative on Affirm Holdings (it's free!)

Affirm Holdings' narrative projects $7.3 billion revenue and $1.2 billion earnings by 2029. This requires 25.0% yearly revenue growth and an earnings increase of about $0.9 billion from $282.3 million today.

Uncover how Affirm Holdings' forecasts yield a $78.93 fair value, a 3% downside to its current price.

Exploring Other Perspectives

The most optimistic analysts were already projecting revenue of about US$8.3 billion and earnings near US$1.7 billion by 2029, so if you worry about partner concentration and promotional loan dependence, it is worth asking whether this latest Bed Bath & Beyond deal and profitability beat bring Affirm closer to that upside path or expose how widely opinions on its future can differ.

Explore 7 other fair value estimates on Affirm Holdings - why the stock might be worth as much as 22% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Affirm Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Affirm Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Affirm Holdings' overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com